INTRODUCTION
Because of the severe shortage of donor allografts for transplantation, thousands of patients every year, throughout the world, suffer significant morbidity and mortality awaiting a suitable kidney, heart, liver or lung transplant. Xenotransplantation, the use of animal organs, would solve this problem and the pig, for a variety of reasons (Fig. l) , is currently perceived to represent the most suitable donor for man.
However, pig organs are 'discordant' in man [l] (and other primates), and suffer an immediate vascular rejection process called hyperacute rejection. Although this has been hitherto regarded as the most formidable barrier to clinical xenotransplantation, there are now several strategies, including the use of organs from transgenic pigs expressing human regulators of complement activity [2] , which offer real hope that this aspect of xenograft rejection will be overcome [3] .
After the recent Kennedy report to the Department of Health [4] , a specialist committee has been established by the British government to oversee the introduction and development of clinical xenotransplantation in the U.K. There are a number of questions, most prominently the risk of infection from xenogeneic organs, that need to be addressed before clinical trials using porcine organs can begin (see Fig. 2 ). Other issues concern the length of time that xenografts transplanted into humans will survive and the adequacy of their performance, although these may be difficult to address in detail before the first patients have been transplanted. Eventually, xenografts will have to survive as long as allografts to solve the problem of organ shortage; short-term survival, with xenografts used only as 'bridging organs' (until an allograft becomes available), may worsen the present situation. Since almost nothing is known about how porcine organs will function in a human environment, it is possible that physiological incompatibilities may limit the survival of these organs. However, it is most likely that immunological rejection will provide the biggest threat to the long-term survival of these organs. Because hyperacute rejection has been such a formidable barrier to breach, the precise nature of the rejection mechanisms beyond this stage is only just emerging from various studies. This article will describe some of these other immunological hurdles and briefly discuss some of the opportunities for novel immunosuppressive strategies. Figure 3 lists the factors important in the pathophysiology of hyperacute rejection and the strategies that may be successful to overcome this clinically. There is a realistic chance that combinations of these will be effective and enable xenografts to survive beyond one or two days. However, there are several other immunological barriers beyond hyperacute rejection [5] (Fig. 4) .
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REJECTION OF XENOGRAFTS: BEYOND HYPERACUTE REJECTION
DELAYED XENOGRAFT REJECTION
The pathophysiology of delayed xenograft rejection is still incompletely understood [12] .
EFFECT OF ANTI-XENOGRAFT ANTIBODIES ON
ENDOTHELIUM. A PARADOX?
The evidence from some models of xenotransplantation supports a role for xenoreactive natural antibodies in the initiation of both hyperacute rejection and delayed xenograft rejection, and consistent with this is the notion that antibody depletion is crucial for accommodation to occur [13] . However, evidence from other models suggests that antixenograft antibody may promote accommodation [14] . How An attractive hypothesis is that accommodation might arise because the endothelium is exposed to a low level of antibody. This was first suggested in general terms (i.e. exposure to low level of stimulus) by Bach et al.
[15], and it might explain why accommodation is associated with antibody depletion [13] . An alternative is that IgM and IgG xenoreactive natural antibodies each have a different effect on endothelial cell physiology. The basis of this might be signalling through different membrane glycoproteins that each isotype is thought to bind. If this was the case, the outcome of rejection or accommodation would be determined by the relative concentrations of each during the period after transplantation. We investigated the first of these possibilities in an in vitro model of porcine endothelial cell accommodation [16] .
In order to ensure that experiments were performed on a phenotypically stable population of endothelial cells, we generated cloned immortalized porcine endothelial cells (IPECs) from primary aortic endothelial cells using a retroviral construct containing the SV40 large T-variant SV-U19 [17] . Clones were chosen for study if they behaved like primary cells during culture and after stimulation with human cytokines. A commercially available preparation of human immunoglobulin [human normal globulin (HNG), BPL, Herts, U.K.] prepared from pooled serum was confirmed to be a rich source of human anti-pig IgG antibodies, as we had expected, since human anti-pig IgG accounts for approximately 1% of total IgG in most individuals [MI.
Two concentrations of HNG, lOOpg/ml (nonsaturating binding by IgG xenoreactive natural antibodies) and 1000 pg/ml (near-saturating) were chosen for investigation. Separate cultures of IPECs were established and maintained for 6days, and HNG was added at different times to individual flasks throughout the culture period. On day 6 all monolayers were harvested simultaneously and the cells examined for changes in phenotype.
One series of experiments examined the sensitivity of these IPECs to the effects of human complement. It was clear that cells incubated in HNG developed a resistance to lysis, demonstrated using standard 51Cr release assays (Fig. 5) . After 120 h the concentration of human serum required to give 50% lysis was increased by a factor of 10. However, there was no apparent relationship between the concentration of HNG with which the IPECs were incubated and the degree of resistance that developed. These experiments were repeated several times to establish that the effect of HNG was real and reproducible. In a full analysis of all these assays (results not shown), the relationship between the length of exposure to HNG and the development of resistance to lysis was still obvious, but best seen under conditions where lysis was limited by the dilution of human serum. The optimal exposure time for development of maximal resistance appeared to be 120 h. In contrast, the concentration of HNG appeared to have little influence on the resistance that developed so that incubation with 100 ,ug/ml had a similar effect to 1000 pglml.
A possible explanation for this protective effect was that preincubation with HNG was saturating xenoreactive antibody binding sites, so that in the cytotoxicity assay complement-king antibodies present in the human serum were prevented from binding to IPECs. However, this was not the case. Maximal binding by complement-king IgM to HNG-incubated IPECs was equivalent or higher than the binding of IgM to control IPECs (results not shown). The implication is that the resistance to lysis by human serum developed because of a real change in the behaviour of IPECs induced by HNG. One possibility that we are currently investigating is that complement regulatory proteins such as CD59, which protect cells against lysis by complement, may be upregulated by exposure to human anti-pig antibodies.
In a second series of experiments we examined the phenotype of cells exposed to HNG. This was done by flow cytometric analyses using monoclonal antibodies specific for E-selectin, vascular cell adhesion molecule (VCAM)-1 and major histocompatibility complex molecule (MHC) class I, chosen primarily because of the availability of pig-specific antibodies. These experiments indicated that a significant downregulation of VCAM and MHC class I expression occurred on IPECs in response to HNG (Fig. 6) . It was also apparent that 100pglml HNG induced greater changes in VCAM and MHC class I than 1000 pglml, and that incubation periods longer than 72 h were required to induce any change in the expression of either molecule. Experiments were also performed to investigate whether incubation with HNG influenced the ability of IPECs to respond to submaximal doses of human recombinant tumour necrosis factor a. Although the reduction in VCAM expression induced by HNG could be overcome by incubation with tumour necrosis factor a, expression remained significantly lower than on control IPECs [16] .
Finally, to investigate the possibility that factors other than IgG anti-pig antibody in the HNG may have been influencing the responses of IPECs, the immunoglobulin fraction was isolated by adsorption on to a recombinant protein G column. Incubation experiments were repeated with this purified immunoglobulin and it was clear that the VCAM modulating ability of HNG resided within the eluted IgG fraction (results not shown). Fig. 7 . Role of xenoreactive natural antibodies in accommodation; a hypothesis. IgM xenoreactive natural antibodies (XNA) promote hyperacute rejection in the presence of complement. Endothelial cell activation, after XNA binding and complement activation, leads to recruitment of platelets and inflammatory leucqes. Individual cells are caused to retract, with consequent loss of monolayer integrity resulting in oedema and exposure of subendothelial tissue factor. This initiates coagulation and leads to widespread intravascular thrombosis. In the absence of complement, XNA deposition is one of the factors thought to promote delayed xenograft rejection during which the endothelium becomes activated and inflammatory monocytes and cells infiltrate into the graft, using Fc-receptor-dependent and porcine-accessory-molecule natural killer (NK) dependent mechanisms. Based on our experimental observations and the observations from in vivo models, we propose that low concentrations of IgG XNA mediate changes in endothelium leading to accommodation several days later. In the absence of complement, hyperacute rejection does not occur. Inflammatory cell traffic into the graft is predicted to be influenced by two things, the absence of significant IgG binding and the downregulation of accessory cell molecules such as VCAM on accommodated cells. Accommodated grafts are therefore also protected from delayed xenograft rejection.
Our results imply that IgG anti-pig antibodies can mediate the development of an accommodated phenotype that is characterized by the development of resistance to complement-mediated lysis and by the downregulation of expression of molecules such as VCAM and MHC class I. Fully accommodated cells developed only after exposure to low concentrations of IgG for at least 4days, supporting the low-level stimulus hypothesis (Fig. 7) . The implications are that the development of accommodation in vivo may be crucially determined by the titre of IgG anti-pig antibodies in the immediate post-transplantation period. This in vitro model is expected to be of value in characterizing further the process of endothelial cell accommodation.
T-CELL RESPONSE TO PORCINE XENOGRAFB
The initiation of T-cell-mediated graft rejection begins with the recognition of graft antigens by specific T-cells (for review see [19] ). Two pathways by which transplantation antigens are recognized have been described [20, 211 . These mechanisms are illustrated in Fig. 8 . In the first, the 'direct' pathway, MHC-expressing allo-or xenogeneic bone-marrowderived specialized antigen-presenting cells provide all the signals required for T-cell activation, including that through the T-cell receptor. Two factors determine the vigour of 'direct' T-cell responses; first, on a cell-to-cell level, the efficiency of interaction between the crucial molecular ligand pairs necessary for T-cell activation; second, at the level of the whole organism, the proportion of T-cells with receptors specific for intact allo-or xeno-MHC. In the case of allogeneic stimulators, efficient molecular interactions and a high frequency of specific T-cells [22] provide the basis for significant primary in vitro alloresponses and strong in vivo cellular responses [23] .
The second recognition pathway, used by CD44 T-cells, is called 'indirect' to reflect the necessity for processing of allo-or xenoantigens before presentation of the peptides generated on cell-surface class (4) released by xenogeneic cells are taken up and processed (5) into peptide fragments by specialized antigen-presenting cells (6) before binding to MHC class II molecules (7) and display on the cell surface (8) for presentation to xenospecific self-MHC-class Il-restricted T-cells. Responder : Stimulator ratio I1 MHC molecules. In these responses, crucial molecular signals leading to T-cell activation and proliferation, provided by recipient antigen-presenting cells, are always efficient and do not limit the vigour of the response. However, in vitro primary indirect alloresponses are difficult to detect for two reasons. First, they are usually obscured by stronger direct responses [24] . Second, the precursor frequency of T-cells specific for processed alloantigen is either undetectable or very low, and although the frequency increases in a secondary mixed lymphocyte reaction [25] it remains approximately 100 times lower than that of T-cells activated by direct allorecognition. For many years the common perception was that T-cell xenoresponses were much weaker than those to alloantigens, a view that arose from in vitro experiments using human and murine mixed lymphocyte cultures, where a series of cross-species molecular incompatibilities are known to limit direct xenorecognition [26] . Very few in vitro studies have been specifically designed to examine the indirect xenoresponse, and until recently no studies had examined the specific human T-cell response to porcine tissue.
B 80-
60-
Using adaptations of protocols designed for use in other species, we isolated and characterized dendritic cell populations from the lungs and peripheral blood of pigs. Dendritic cells (DCs) were chosen as stimulator cells in these experiments for two reasons. First, they correspond to the lineage that is most likely to play a major role in provoking a direct response in vivo after clinical xenotransplantation [19] . Second, because it was possible to isolate human and porcine DCs simultaneously from peripheral blood using the same protocols, a meaningful comparison could be made between allo-and xenogeneic responses.
The results of these experiments are illustrated in Fig. 9 and Table 1 . Under conditions where stimulator cells were in excess, these 'direct' anti-pig xenoresponses appeared equivalent in strength to direct alloresponses, with a high precursor frequency of pig-specific T-cells. These responses were mediated by human CD4+ T-cells recognizing swine leucocyte antigen (SLA)-DR molecules [27] . SLA is the name given to porcine MHC molecules. However, under conditions where the numbers of stimulator cells were limiting, 'direct' proliferative anti-pig xenoresponses appeared weaker than alloresponses [28, 291 . The implication was that there might be qualitative 'defects' in the molecular interactions involved in the human anti-pig direct xenoresponse, so experiments were performed to investigate the provision of cognate and non-cognate interactions to human T-cells by porcine ligands.
A Problems with systemic immunosuppression
) Relatively ineffective at preventing duoruc rejection; chronic .ejection of xenografts may be more aggressive than that of Examination of accessory and co-stimulatory signals revealed that porcine VCAM interacted efficiently with human VLA-4 to promote T-cell adhesion and proliferation under certain conditions [16] . Similarly, porcine B7 was found to provide efficient co-stimulatory signals for human T-cell proliferation and interleukin-2 production (see the legend to Fig. 8 for a definition of these accessory molecules). Overall, porcine cells were able to support human T-cell proliferation at least as well as human accessory cells, implying adequate provision of non-cognate interactions by pig ligands [28] . Results from other groups corroborate this conclusion [30, 311. The molecular basis of the weakened direct response was traced, at least in part, to an inefficient interaction between SLA-DR and human T-cells. This is illustrated in Fig. 10 and Table 2 . Human T-cell proliferative responses to transfectant murine DAP.3 clones expressing SLA-DR were always reduced compared with those expressing HLA-DR1. Limiting dilution analyses revealed that approximately 3-5 times fewer human T-cells had specificity for xeno-compared with allogeneic MHC. Comparison of the responses to these two MHC class I1 molecules was particularly informative because of their remarkable similarity; the predicted primary amino acid sequence of the Pl domain of c-haplotype SLA-DR is more like HLA-DR1 than many other HLA-DRP alleles [32] , and SLA-DRc probably represents the most 'human-like' of the porcine MHC molecules. By implication, the human T-cell responses to SLA-DRc will be the most 'allogeneic-like' of the human responses to porcine SLA-DR.
The other mechanism by which T-cell responses to xenografts may be initiated is by 'indirect' recognition of xenoantigens. We examined the indirect response to pig antigens using SLA-class II-negative or co-stimulator-deficient porcine stimulator cells that were unable to provoke a direct response [27, 33, 341 . These results, illustrated in Fig. 11 and Table 3 , indicate that the frequency of HLA-class II-restricted CD4+ T-cells with specificity for pro-cessed pig xenoantigens was much higher than the equivalent frequency of cells specific for processed alloantigen. Consequently, primary indirect proliferative responses were easily observed against porcine, but not against allogeneic stimulators.
Several possibilities were considered to account for strong indirect xenoresponses. First, the presence of xenospecific B-cells, responsible for production of xenoreactive natural antibodies, might have acted as efficient antigen-presenting cells for porcine antigens. The unique antigen-concentrating abilities of antigen-specific B-cells have been well documented [35] . However, B-cell-depleted human responders were equally as efficient as B-cell-replete populations at mounting indirect anti-pig responses, effectively ruling out this explanation. These results do not address the question of whether the presence of xenoreactive natural antibodies contributes to antigen uptake and processing by conventional Fc-receptor-expressing antigen-presenting cells.
The second possibility was that T-cell xenoresponses may have been primed by exposure to antigens shared between environmental pathogens and xenostimulator populations or by exposure to antigens present within food. Oral priming after ingestion of antigens has been documented in some animal models [36] . However, naive T-cells, obtained from umbilical cord specimens, mounted indirect responses as effectively as those from adults, implying that priming was not necessary.
We have concluded therefore that indirect xenoresponses are stronger than alloresponses mainly because of the greater number of xenoantigens compared with alloantigens. This in turn is most probably due to the high degree of protein polymorphisms across different species, in contrast to the limited polymorphism between individual humans.
SUMMARY OF HUMAN T-CELL ANTI-PIG
XENORESPONSES
Direct recognition of pig stimulators by human T-cells appears efficient and results in significant primary proliferative responses, although under certain conditions the response is reproducibly weaker than equivalent alloresponses. Our observation that porcine MHC class I1 molecules are recognized less efficiently than their allogeneic counterparts is interesting and clearly illustrates the general point that intercellular molecular interactions tend to be less efficient across species barriers, but it is probably without any direct practical relevance. In-vivo, where stimulator cell numbers are unlikely to be limiting, the vigour of anti-xenograft rejection will probably resemble the vigour of anti-allograft rejection.
Human HLA-DR-restricted T-cells also mount significant indirect proliferative responses to processed porcine xenoantigens, and these are likely to play a major role in initiating and perpetuating acute cellular rejection in vivo.
The available evidence therefore suggests that a formidable T-cell response to porcine antigens will develop in recipients of pig organs.
XENOGRAFT-SPECIFIC IMMUNOSUPPRESSION
Whether post-hyperacute rejection immune barriers will eventually yield to conventional immunosuppressive therapies is still uncertain; the newer, more potent pharmacological agents may be required routinely in xenograft recipients [26] .
However, if xenotransplantation becomes a reality, there will be exciting opportunities to develop new methods of immunosuppression, with an emphasis on tailored, or graft-specific approaches allowing a shift away from complete reliance on systemic immunosuppression (Fig. 12) .
For instance, the results of our in vitro studies, along with those from other groups [37] , have provided insights into the potential mechanisms underlying accommodation, and it may be possible in the future to manipulate the xenograft to induce accommodation before, or at the time of transplantation. In addition, our detailed examination of the in vitro human anti-pig cellular xenoresponses, like those from other groups [38, 391, has established a rationale for the design of tailored immunosuppressive strategies. In this context, targeting and tolerizing xenospecific T-cells may be easier to achieve than has been possible for allospecific cells; for example, pig-specific monoclonal antibody therapy, targeting molecules involved in T-cell activation, may be an effective means of inducing tolerance in graft-reactive T-cells (see Fig. 12 for other examples).
The next major challenge in xenotransplantation research, now that hyperacute rejection has been overcome, is to exploit these opportunities in full to achieve long-term graft survival and reduce the need for systemic immunosuppression.
